FDA approves injection that would boost women's sex drive

The Food and Drug Administration on Friday approved Vyleesi, an injection designed to heighten women's sex drive.

Bremelanotide Injection: MedlinePlus Drug Information

Bremelanotide injection is used to treat women with hypoactive sexual desire disorder (HSDD; a low sexual desire that causes distress or interpersonal difficulty) who have not experienced menopause (change of life; the end of monthly menstrual periods); who have not had problems with low sexual desire in the past; and whose low sexual desire is not due to a medical or mental health problem, a ...

Women's Wellness: Libido drug to help women with low sexual desire

A new drug for premenopausal women with low sexual desire has been approved by the Food and Drug Administration (FDA).. Vyleesi (bremelanotide injection), is designed to treat low libido in women, known as hypoactive sexual desire disorder.This disorder is characterized by low sexual desire that's not related to an other issue, such as a medical condition, relationship issues or lack of sex ...

About Vyleesi | Approved Bremelanotide Injection for HSDD

*Do not take Vyleesi more than one time within 24 hours or more than 8 times per month. † Serious adverse reactions were reported in 1.1% of Vyleesi-treated patients and 0.5% of placebo-treated patients. ‡ After completing the 24-week double-blind study period, 242 participants completed a voluntary exit survey to provide additional context to the clinical trial data.

FDA approves new treatment for hypoactive sexual desire disorder in ...

In 2012, the FDA identified female sexual dysfunction as one of 20 disease areas of high priority and focused attention. The FDA held a two-day meeting in October 2014 to advance the agency's ...